• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

既往围生期心肌病患者再次妊娠的当代结局。

Contemporary outcome of subsequent pregnancies in patients with previous peripartum cardiomyopathy.

机构信息

The Heart Institute, Kaplan Medical Center, Rehovot, Israel.

Hadassah Medical School, Hebrew University, Jerusalem, Israel.

出版信息

ESC Heart Fail. 2022 Dec;9(6):4262-4270. doi: 10.1002/ehf2.14141. Epub 2022 Sep 20.

DOI:10.1002/ehf2.14141
PMID:36128657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9773727/
Abstract

AIMS

To describe the effect of subsequent pregnancies (SSP) on left ventricular (LV) function and outcomes in patients with peripartum cardiomyopathy (PPCM).

METHODS

Among146 women with PPCM who were prospectively followed at two medical centres in Israel (2007-2019), 75 SSPs (in 50 women) were identified: 8 miscarriages, 8 terminations, and 59 life birth.

RESULTS

Forty-five patients with 59 full-term SSPs [mean age was 32.9 ± 4.1 years, LV ejection fraction (LVEF) 57.7 ± 5.1%] were analysed. Data on LVEF at 1-month post-delivery were available in 46 and at 6 months in 36 SSPs. There was a small decrease in the mean LVEF, mostly at third trimester (57.2 ± 5.6 vs. 54.4. ± 7.3, P < 0.001); and at 1-mont (57.9 ± 5.7% vs. 55.4 ± 6.1%, P = 0.001) and at 6-month post-delivery (57.4 ± 6.1 vs. 55.3 ± 7.9%, P = 0.03). In patients with pre-SSP LV LVEF ≥55%, a mild reduction in the mean group LVEF was seen at 1-month post-delivery (P = 0.009). One patient with pre-SSP LVEF ≥55% developed severe relapse. In patients with pre-SSP LVEF <55%, a mild reduction in LVEF was obtained mostly at third trimester (51.1 ± 5.6 vs 47.0 ± 7.4%, P < 0.001), which persisted at 6 months (P = 0.03). A relapse was observed in three (25%) women with LVEF <55%. There was no maternal mortality, 32 patients delivered by caesarean section, and there were no foetal complications.

CONCLUSIONS

Our study indicates a favourable outcome and low likelihood of maternal mortality associated with SSP in women with a history of PPCM and recovered LV systolic function. SSP was associated with a slight reduction in LVEF mostly during the third trimester, which persisted up to 6 months after delivery.

摘要

目的

描述围产期心肌病(PPCM)患者再次妊娠(SSP)对左心室(LV)功能和结局的影响。

方法

在以色列的两个医疗中心对 146 名 PPCM 患者进行前瞻性随访(2007-2019 年),确定了 75 例 SSP(50 名患者):8 例流产,8 例终止妊娠,59 例活产。

结果

对 45 名患者的 59 例足月 SSP(平均年龄 32.9±4.1 岁,左心室射血分数[LVEF]为 57.7±5.1%)进行了分析。46 例患者产后 1 个月时 LVEF 数据可用,36 例患者产后 6 个月时 LVEF 数据可用。LVEF 在第三个月(57.2±5.6 对 54.4.±7.3,P<0.001)和产后 1 个月(57.9±5.7%对 55.4±6.1%,P=0.001)和产后 6 个月(57.4±6.1%对 55.3±7.9%,P=0.03)时均有轻微下降。在有 SSP 前 LVEF≥55%的患者中,在产后 1 个月时观察到平均 LVEF 有轻度下降(P=0.009)。1 例 SSP 前 LVEF≥55%的患者发生严重复发。在 SSP 前 LVEF<55%的患者中,LVEF 在第三个月(51.1±5.6 对 47.0±7.4%,P<0.001)和 6 个月时(P=0.03)均有轻度下降。3 名(25%)LVEF<55%的患者出现复发。无孕产妇死亡,32 名患者行剖宫产,无胎儿并发症。

结论

本研究表明,在 PPCM 病史和恢复左心室收缩功能的女性中,再次妊娠(SSP)的结局良好,发生母亲死亡的可能性较低。SSP 与 LVEF 略有下降有关,主要发生在第三个月,产后 6 个月仍持续存在。

相似文献

1
Contemporary outcome of subsequent pregnancies in patients with previous peripartum cardiomyopathy.既往围生期心肌病患者再次妊娠的当代结局。
ESC Heart Fail. 2022 Dec;9(6):4262-4270. doi: 10.1002/ehf2.14141. Epub 2022 Sep 20.
2
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.既往有围生期心肌病病史患者的后续妊娠结局。
Eur J Heart Fail. 2017 Dec;19(12):1723-1728. doi: 10.1002/ejhf.808. Epub 2017 Mar 27.
3
Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.伊拉克围产期心肌病:基于初始登记的资料和 6 个月的结局。
ESC Heart Fail. 2021 Oct;8(5):4048-4054. doi: 10.1002/ehf2.13502. Epub 2021 Jun 28.
4
Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis.围生期心肌病患者再次妊娠的结局:系统评价和荟萃分析。
Open Heart. 2024 Apr 2;11(1):e002626. doi: 10.1136/openhrt-2024-002626.
5
Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum Cardiomyopathy.基于影像学的产后心肌病病史女性复发风险分层。
Am J Perinatol. 2022 Feb;39(3):225-231. doi: 10.1055/s-0041-1740016. Epub 2021 Dec 2.
6
Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.围生期心肌病患者的后续生殖结局:一项全国性研究。
BJOG. 2018 Jul;125(8):1018-1025. doi: 10.1111/1471-0528.15046. Epub 2017 Dec 10.
7
Long-Term Outcomes of Women With Peripartum Cardiomyopathy Having Subsequent Pregnancies.围生期心肌病患者再次妊娠的长期结局。
J Am Coll Cardiol. 2023 Jul 4;82(1):16-26. doi: 10.1016/j.jacc.2023.04.043.
8
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).北美围产期心肌病的临床结局:IPAC研究(妊娠相关心肌病调查)结果
J Am Coll Cardiol. 2015 Aug 25;66(8):905-14. doi: 10.1016/j.jacc.2015.06.1309.
9
Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.评估美国围产期心肌病女性基线左心室射血分数作为严重心功能障碍恢复或持续存在的预测因子的临床相关性。
J Card Fail. 2011 May;17(5):426-30. doi: 10.1016/j.cardfail.2011.01.007. Epub 2011 Mar 11.
10
Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome.丹麦围产期心肌病:一项回顾性、基于人群的发病率、治疗方法和结局研究。
Eur J Heart Fail. 2017 Dec;19(12):1712-1720. doi: 10.1002/ejhf.882. Epub 2017 Jun 8.

引用本文的文献

1
Diagnostic and Therapeutic Challenges Between Peripartum and Influenza-Induced Inflammatory Cardiomyopathy-A Case Report and Literature Review.围产期心肌病与流感诱发的炎症性心肌病之间的诊断和治疗挑战——病例报告及文献综述
J Clin Med. 2025 May 14;14(10):3440. doi: 10.3390/jcm14103440.
2
Maternal and fetal outcomes in subsequent pregnancies after peripartum cardiomyopathy: A systematic review and meta-analysis.产后心肌病后后续妊娠的母婴结局:一项系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2025 Jun;104(6):1009-1025. doi: 10.1111/aogs.15117. Epub 2025 Apr 30.
3
Diagnosis and management of peripartum cardiomyopathy and recurrence risk.

本文引用的文献

1
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.围生期心肌病患者的临床表现、处理和 6 个月结局:ESC-EORP 注册研究。
Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455.
2
Peripartum Cardiomyopathy: JACC State-of-the-Art Review.围生期心肌病:美国心脏病学会临床心脏病学实践中的现状综述。
J Am Coll Cardiol. 2020 Jan 21;75(2):207-221. doi: 10.1016/j.jacc.2019.11.014.
3
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
围产期心肌病的诊断、管理及复发风险
Int J Cardiol Congenit Heart Dis. 2024 Jul 19;17:100530. doi: 10.1016/j.ijcchd.2024.100530. eCollection 2024 Sep.
4
Subsequent pregnancies in peripartum cardiomyopathy: Patient-level differences and decision-making.围产期心肌病患者的后续妊娠:个体差异与决策制定
Am Heart J Plus. 2024 Oct 11;47:100472. doi: 10.1016/j.ahjo.2024.100472. eCollection 2024 Nov.
5
What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.关于围产期心肌病,我们了解多少?昨天、今天、明天。
Int J Mol Sci. 2024 Sep 30;25(19):10559. doi: 10.3390/ijms251910559.
6
Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis.围生期心肌病患者再次妊娠的结局:系统评价和荟萃分析。
Open Heart. 2024 Apr 2;11(1):e002626. doi: 10.1136/openhrt-2024-002626.
7
Five cases of Peripartum Cardiomyopathy in Malawi.马拉维的五例围产期心肌病。
Malawi Med J. 2023 Sep;35(3):196-200. doi: 10.4314/mmj.v35i3.10.
围生期心肌病的病理生理学、诊断和治疗:欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
4
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.2018年欧洲心脏病学会妊娠期心血管疾病管理指南。
Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340.
5
Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy.患有围产期心肌病的非洲黑人女性再次妊娠的母婴预后
BMC Cardiovasc Disord. 2018 Jun 18;18(1):119. doi: 10.1186/s12872-018-0856-7.
6
Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.围生期心肌病的长期预后、再次妊娠、避孕和整体管理:欧洲心脏病学会心力衰竭协会围生期心肌病研究组实践指导文件。
Eur J Heart Fail. 2018 Jun;20(6):951-962. doi: 10.1002/ejhf.1178. Epub 2018 Mar 26.
7
Subsequent Pregnancy Outcomes in Patients With Peripartum Cardiomyopathy.围生期心肌病患者的后续妊娠结局。
Obstet Gynecol. 2018 Feb;131(2):322-327. doi: 10.1097/AOG.0000000000002439.
8
Reducing the risks for relapse of heart failure in a subsequent pregnancy after peripartum cardiomyopathy?降低围产期心肌病后再次妊娠时心力衰竭复发的风险?
Future Cardiol. 2017 Jul;13(4):305-310. doi: 10.2217/fca-2017-0029. Epub 2017 Jun 16.
9
Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.既往有围生期心肌病病史患者的后续妊娠结局。
Eur J Heart Fail. 2017 Dec;19(12):1723-1728. doi: 10.1002/ejhf.808. Epub 2017 Mar 27.
10
Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients.产后心肌病康复患者的血管生成失衡与残留心肌损伤
Circ Heart Fail. 2016 Nov;9(11). doi: 10.1161/CIRCHEARTFAILURE.116.003349.